Obesity, type 2 diabetes and cancers of the digestive system
Authors:
- 27 February 2026
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 121, 1-21
Abstract
No abstract availableKeywords
This publication has 292 references indexed in Scilit:
- Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 DiabetesJAMA Network Open, 2024
- GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/ObesityJAMA Oncology, 2024
- A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factorsCancer Communications, 2021
- Statins and metformin for chemoprevention of hepatocellular carcinomaClinical Liver Disease, 2016
- Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta‐analysis of observational studiesDiabetes/Metabolism Research and Reviews, 2015
- Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancerBritish Journal of Surgery, 2013
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studiesInternational Journal of Cancer, 2011
- Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal‐transduction pathwaysInternational Journal of Cancer, 2008
- Body mass index and pancreatic cancer risk: A meta‐analysis of prospective studiesInternational Journal of Cancer, 2007
- Diabetes Mellitus as a Risk Factor for Pancreatic CancerJAMA, 1995